Agilon Health Inc. (NYSE: AGL) reported Q1 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $653 million versus the consensus estimate of $590.02 million.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.